IBM stock gets a five-year USTA renewal and AI showcase
Boeing stock: Q3 loss narrows as commercial recovery stays uneven
Northrop Grumman stock gains momentum from backlog and guidance
MercadoLibre stock gains 3.17% before November 4 results
Barrick Mining stock gains 3.64% ahead of November results
Loblaw stock faces a scale test as Morningstar flags competitive limits
Cencora stock target raised to USD 377 before earnings
DoorDash stock expands holiday services with catering and returns
Gilead Sciences stock heads into Denver with new liver data
Blackstone stock: AUM reaches USD 1.37 trillion as dividend date arrives
Cheniere Energy stock: LNG quote falls 3.74% since latest report
American Tower stock gets third outlook raise as data centers lead
NextEra Energy stock adds 3.7 GW to project backlog
Apollo Global Management stock heads into Tuesday's Q3 results
Rolls-Royce's Hong Kong Maintenance Milestone Meets a Harder Test in November
Berkshire Heads Into Q3 With Revenue Forecasts Rising but Per-Share Profit Set to Slip
PNE Completes 250 MW South African Solar Sale While Buy Ratings Survive Target Cuts
Alphabet's Search Engine Is Asking a Harder Question: Who Pays for the Clicks?
AIA Group stock enters new regional leadership phase
EQS-CMS: Deutsche Telekom AG: Release of a capital market information
SK Hynix stock slips as record quarter meets AI-memory investment test
AppLovin stock approaches Nov. 4 results as ad growth faces test
CME Group stock adds five dry-freight futures on November 2
UOB stock falls 1.6% ahead of November 4 results
Westpac stock: FY26 profit slips as dividend holds steady
Cigna Group stock faces November 5 earnings release before open
Constellation Energy stock gets conditional DOE backing
Danaher stock heads into November 4 sepsis diagnostics session
ServiceNow's 21% Growth Was Never in Doubt — the 18.5% Forward Guide Is What Broke the Spell
HDFC Bank stock enters final week before CEO vote
Astera Labs stock heads into earnings with Orion in focus
IREN Keeps Its Buy Rating but Loses $27 of Price Target as Capital Costs Take Centre Stage
BioNTech's October: A Gilead Trial Pact, a Melbourne Plant, and Two Readouts That Refuse to Flatter
CATL Extends Battery Lead to 39.1% as Dongfeng Deal Widens Charging and Swap Reach
Mercedes-Benz Buyback Rolls On as Analysts Split and China Strategy Awaits Rewrite